| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $23.7M | +700.6% |
| Cost of Revenue | $7.4M | — |
| R&D Expense | $16.0M | -21.7% |
| SG&A Expense | $34.1M | +176.3% |
| Operating Income | -$34.2M | -14.4% |
| Interest Expense | $1.5M | — |
| Income Tax | $0 | — |
| Net Income | -$31.3M | -5.5% |
| EPS (Basic) | -$1.42 | +18.4% |
| EPS (Diluted) | -$1.42 | +18.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.3M | -73.8% |
| Accounts Receivable | $22.0M | +391.9% |
| Inventory | $1.2M | — |
| Current Assets | $42.4M | -21.7% |
| Total Assets | $90.3M | +31.0% |
| Current Liabilities | $46.4M | +316.1% |
| Total Liabilities | $85.7M | +69.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.9M | -24.6% |
| Capital Expenditures | $4.3M | -52.8% |
| Investing Cash Flow | -$18.9M | -150.6% |
| Financing Cash Flow | $16.0M | -63.7% |
| Free Cash Flow | -$35.2M | -3.9% |
| Stockholders' Equity |
| $4.6M |
| -74.9% |